Wall Street Zen Downgrades Adtalem Global Education (NYSE:CVSA) to Hold

Key Points

• Wall Street Zen downgraded Adtalem Global Education from a buy to a hold rating, adding to a mixed analyst picture for the stock.
• The company reported strong fiscal Q4 results, with EPS of $1.98 beating estimates and revenue rising 4.5% year over year to $487.03 million; it also raised FY2026 guidance to $7.95-$8.15 EPS.
• Shares were up 13.4% and traded around $132.68, while insider buying remained notable, including a director purchase earlier this year and $3.75 million in insider purchases over the last three months.

Adtalem Global Education (NYSE:CVSA - Get Free Report) was downgraded by analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a note issued to investors on Saturday.

Several other equities analysts also recently commented on the company. Truist Financial initiated coverage on Adtalem Global Education in a research report on Tuesday, March 24th. They issued a "buy" rating and a $130.00 target price on the stock. Weiss Ratings initiated coverage on Adtalem Global Education in a research report on Wednesday, February 25th. They issued a "hold (c+)" rating on the stock. Zacks Research downgraded Adtalem Global Education from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, March 25th. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $170.00 target price on shares of Adtalem Global Education in a research report on Friday, April 17th. Two analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $150.00.

Adtalem Global Education Trading Up 13.4%

CVSA opened at $132.68 on Friday. Adtalem Global Education has a 1-year low of $86.97 and a 1-year high of $156.26. The firm has a fifty day simple moving average of $110.78. The company has a current ratio of 0.68, a quick ratio of 0.68 and a debt-to-equity ratio of 0.37. The company has a market cap of $4.58 billion, a PE ratio of 20.67, a PEG ratio of 0.99 and a beta of 0.63.

Adtalem Global Education (NYSE:CVSA - Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. The company reported $1.98 earnings per share for the quarter, beating analysts' consensus estimates of $1.73 by $0.25. Adtalem Global Education had a return on equity of 19.98% and a net margin of 12.26%.The business had revenue of $487.03 million for the quarter. During the same quarter last year, the company posted $1.92 EPS. The firm's revenue was up 4.5% on a year-over-year basis. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. Equities analysts forecast that Adtalem Global Education will post 7.86 earnings per share for the current year.

Insider Activity

In related news, Director Michael W. Malafronte purchased 8,890 shares of the business's stock in a transaction that occurred on Wednesday, March 11th. The stock was acquired at an average cost of $100.94 per share, for a total transaction of $897,356.60. Following the completion of the purchase, the director owned 25,395 shares in the company, valued at approximately $2,563,371.30. This represents a 53.86% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders purchased 37,236 shares of company stock valued at $3,752,866 in the last three months. Insiders own 2.50% of the company's stock.

Adtalem Global Education Company Profile

Adtalem Global Education NYSE: CVSA is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.